trending Market Intelligence /marketintelligence/en/news-insights/trending/if3f46ffnuRTcoRMqca7YQ2 content esgSubNav
In This List

Veloxis Pharmaceuticals appoints chief commercial officer

Blog

Post-webinar Q&A: Global Credit Risk Trends 2021 and Beyond

Blog

University Essentials: From Crisis to Resilience – Navigating Sustainable Recovery

Blog

EV impact; vaccines to boost job market; coal supply constraints

Blog

Shore Capital is Now Available in S&P Global’s Aftermarket Research Collection


Veloxis Pharmaceuticals appoints chief commercial officer

Veloxis Pharmaceuticals A/S promoted Mark Hensley to the role of chief commercial officer.

Hensley has been serving as the company's vice president of sales since May 2017. He also held different senior leadership roles in Chiesi USA Inc. and Cornerstone Therapeutics Inc. before joining Veloxis.

Copenhagen-based Veloxis Pharmaceuticals is a specialty pharmaceutical company that develops and commercializes products used in transplant procedures and adjacent therapies.